GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies

dc.contributor.authorGoldkuhle, Marius
dc.contributor.authorBender, Ralf
dc.contributor.authorAkl, Elie A.
dc.contributor.authorvan Dalen, Elvira C.
dc.contributor.authorNevitt, Sarah Jane
dc.contributor.authorMustafa, Reem A.
dc.contributor.authorGordon, Guyatt H.
dc.contributor.authorTrivella, Marialena
dc.contributor.authorDjulbegović, Benjamin J.
dc.contributor.authorSchunëmann, Holger J.
dc.contributor.authorCinquini, Michela
dc.contributor.authorKreuzberger, Nina
dc.contributor.authorSkoetz, Nicole
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:06Z
dc.date.available2025-01-24T11:43:06Z
dc.date.issued2021
dc.description.abstractObjectives: To provide Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidance for the consideration of study limitations (risk of bias) due to missing participant outcome data for time-to-event outcomes in intervention studies. Study Design and Setting: We developed this guidance through an iterative process that included membership consultation, feedback, presentation, and iterative discussion at meetings of the GRADE working group. Results: The GRADE working group has published guidance on how to account for missing participant outcome data in binary and continuous outcomes. When analyzing time-to-event outcomes (e.g., overall survival and time-to-treatment failure) data of participants for whom the outcome of interest (e.g., death and relapse) has not been observed are dealt with through censoring. To do so, standard methods require that censored individuals are representative for those remaining in the study. Two types of censoring can be distinguished, end of study censoring and censoring because of missing data, commonly named loss to follow-up censoring. However, both types are not distinguishable with the usual information on censoring available to review authors. Dealing with individuals for whom data are missing during follow-up in the same way as individuals for whom full follow-up is available at the end of the study increases the risk of bias. Considerable differences in the treatment arms in the distribution of censoring over time (early versus late censoring), the overall degree of missing follow-up data, and the reasons why individuals were lost to follow-up may reduce the certainty in the study results. With often only very limited data available, review and guideline authors are required to make transparent and well-considered judgments when judging risk of bias of individual studies and then come to an overall grading decision for the entire body of evidence. Conclusion: Concern for risk of bias resulting from censoring of participants for whom follow-up data are missing in the underlying studies of a body of evidence can be expressed in the study limitations (risk of bias) domain of the GRADE approach. © 2020 Elsevier Inc.
dc.identifier.doihttps://doi.org/10.1016/j.jclinepi.2020.09.017
dc.identifier.eid2-s2.0-85093647137
dc.identifier.pmid33007458
dc.identifier.urihttp://hdl.handle.net/10938/30200
dc.language.isoen
dc.publisherElsevier Inc.
dc.relation.ispartofJournal of Clinical Epidemiology
dc.sourceScopus
dc.subjectCensoring missing data
dc.subjectCertainty of the evidence
dc.subjectGrade
dc.subjectLoss to follow-up
dc.subjectRisk of bias
dc.subjectSurvival analysis
dc.subjectTime-to-event outcomes
dc.subjectBias
dc.subjectClinical studies as topic
dc.subjectGrade approach
dc.subjectHumans
dc.subjectLost to follow-up
dc.subjectOutcome assessment, health care
dc.subjectPatient dropouts
dc.subjectResearch design
dc.subjectRisk assessment
dc.subjectArticle
dc.subjectCensorship
dc.subjectData completeness
dc.subjectFollow up
dc.subjectInformation processing
dc.subjectOutcome assessment
dc.subjectPractice guideline
dc.subjectPriority journal
dc.subjectTime to event outcome
dc.subjectClinical study
dc.subjectHuman
dc.subjectMethodology
dc.subjectOrganization and management
dc.subjectPatient dropout
dc.subjectProcedures
dc.subjectStatistical bias
dc.titleGRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-2996.pdf
Size:
757.97 KB
Format:
Adobe Portable Document Format